Longeveron (LGVN) Competitors $1.46 +0.02 (+1.04%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$1.50 +0.04 (+2.74%) As of 09:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LGVN vs. JMAC, ANIX, XCUR, SNTI, BDTX, PLRX, VIGL, BMEA, ADVM, and THTXShould you be buying Longeveron stock or one of its competitors? The main competitors of Longeveron include Maxpro Capital Acquisition (JMAC), Anixa Biosciences (ANIX), Exicure (XCUR), Senti Biosciences (SNTI), Black Diamond Therapeutics (BDTX), Pliant Therapeutics (PLRX), Vigil Neuroscience (VIGL), Biomea Fusion (BMEA), Adverum Biotechnologies (ADVM), and Theratechnologies (THTX). These companies are all part of the "pharmaceutical products" industry. Longeveron vs. Maxpro Capital Acquisition Anixa Biosciences Exicure Senti Biosciences Black Diamond Therapeutics Pliant Therapeutics Vigil Neuroscience Biomea Fusion Adverum Biotechnologies Theratechnologies Maxpro Capital Acquisition (NASDAQ:JMAC) and Longeveron (NASDAQ:LGVN) are both small-cap manufacturing companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership. Do analysts recommend JMAC or LGVN? Longeveron has a consensus price target of $8.67, suggesting a potential upside of 493.61%. Given Longeveron's stronger consensus rating and higher probable upside, analysts clearly believe Longeveron is more favorable than Maxpro Capital Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Maxpro Capital Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Longeveron 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Does the MarketBeat Community favor JMAC or LGVN? Longeveron received 18 more outperform votes than Maxpro Capital Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformMaxpro Capital AcquisitionN/AN/ALongeveronOutperform Votes1894.74% Underperform Votes15.26% Is JMAC or LGVN more profitable? Maxpro Capital Acquisition has a net margin of 0.00% compared to Longeveron's net margin of -967.49%. Maxpro Capital Acquisition's return on equity of 0.00% beat Longeveron's return on equity.Company Net Margins Return on Equity Return on Assets Maxpro Capital AcquisitionN/A N/A N/A Longeveron -967.49%-142.43%-100.84% Which has better earnings and valuation, JMAC or LGVN? Maxpro Capital Acquisition has higher earnings, but lower revenue than Longeveron. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMaxpro Capital AcquisitionN/AN/AN/AN/AN/ALongeveron$2.39M9.11-$21.41M-$6.28-0.23 Do institutionals and insiders hold more shares of JMAC or LGVN? 73.2% of Maxpro Capital Acquisition shares are held by institutional investors. Comparatively, 10.0% of Longeveron shares are held by institutional investors. 19.3% of Maxpro Capital Acquisition shares are held by insiders. Comparatively, 19.1% of Longeveron shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media favor JMAC or LGVN? In the previous week, Longeveron had 1 more articles in the media than Maxpro Capital Acquisition. MarketBeat recorded 1 mentions for Longeveron and 0 mentions for Maxpro Capital Acquisition. Longeveron's average media sentiment score of 1.89 beat Maxpro Capital Acquisition's score of 0.00 indicating that Longeveron is being referred to more favorably in the news media. Company Overall Sentiment Maxpro Capital Acquisition Neutral Longeveron Very Positive Which has more risk & volatility, JMAC or LGVN? Maxpro Capital Acquisition has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, Longeveron has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500. SummaryLongeveron beats Maxpro Capital Acquisition on 9 of the 14 factors compared between the two stocks. Remove Ads Get Longeveron News Delivered to You Automatically Sign up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LGVN vs. The Competition Export to ExcelMetricLongeveronPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.80M$6.33B$5.33B$7.57BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-0.236.8121.7017.82Price / Sales9.11225.96377.7294.61Price / CashN/A65.6738.1534.64Price / Book0.545.866.464.00Net Income-$21.41M$141.86M$3.20B$247.23M7 Day Performance6.57%4.38%2.77%1.44%1 Month Performance-13.61%-12.76%-8.60%-6.26%1 Year Performance-58.64%-11.13%10.40%0.59% Longeveron Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LGVNLongeveron2.9991 of 5 stars$1.46+1.0%$8.67+493.6%-50.2%$21.80M$2.39M-0.2320Positive NewsJMACMaxpro Capital AcquisitionN/A$6.00-10.6%N/A-45.0%$80.57MN/A0.002,021Gap UpANIXAnixa Biosciences2.9044 of 5 stars$2.49-1.6%$9.00+261.4%-9.8%$80.17M$210,000.00-6.385Gap UpXCURExicure1.784 of 5 stars$12.48-4.0%N/A+1,823.4%$78.82M$500,000.00-6.0350Short Interest ↓News CoverageGap DownSNTISenti Biosciences2.7608 of 5 stars$2.97+1.7%$10.00+236.7%+21.8%$77.23M$2.56M-0.194Short Interest ↑BDTXBlack Diamond Therapeutics3.1369 of 5 stars$1.36-2.9%$14.60+973.5%-72.8%$77.06MN/A-1.0290Short Interest ↑Gap DownPLRXPliant Therapeutics4.2236 of 5 stars$1.25-6.7%$13.31+965.0%-89.2%$76.55M$1.58M-0.3790Positive NewsVIGLVigil Neuroscience3.1967 of 5 stars$1.54-1.3%$16.25+955.2%-50.9%$75.65MN/A-0.7540Positive NewsBMEABiomea Fusion2.6621 of 5 stars$2.01-5.2%$23.91+1,089.5%-86.2%$75.52MN/A-0.5050Positive NewsADVMAdverum Biotechnologies3.9585 of 5 stars$3.63-6.0%$27.83+666.8%-72.0%$75.51M$1M-0.61190Earnings ReportAnalyst ForecastNews CoverageGap DownTHTXTheratechnologiesN/A$1.64+10.8%N/A+104.6%$75.41M$85.87M-16.40140Short Interest ↑Analyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies JMAC Alternatives ANIX Alternatives XCUR Alternatives SNTI Alternatives BDTX Alternatives PLRX Alternatives VIGL Alternatives BMEA Alternatives ADVM Alternatives THTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LGVN) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Longeveron Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Longeveron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LGVN Stock Free LGVN Stock Alerts